 Marie Jette
Concepts (156)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Larynx | 4 | 2020 | 60 | 1.230 |
Why?
| | Vocal Cords | 7 | 2017 | 32 | 0.980 |
Why?
| | Gastroesophageal Reflux | 3 | 2016 | 235 | 0.910 |
Why?
| | Chemoreceptor Cells | 2 | 2020 | 54 | 0.770 |
Why?
| | Laryngeal Mucosa | 2 | 2019 | 8 | 0.690 |
Why?
| | Respiration Disorders | 1 | 2020 | 77 | 0.660 |
Why?
| | Vocal Cord Paralysis | 1 | 2019 | 29 | 0.650 |
Why?
| | Arytenoid Cartilage | 1 | 2019 | 7 | 0.630 |
Why?
| | Laryngostenosis | 1 | 2019 | 51 | 0.630 |
Why?
| | Airway Obstruction | 1 | 2020 | 162 | 0.610 |
Why?
| | Deglutition Disorders | 1 | 2019 | 143 | 0.570 |
Why?
| | Laryngopharyngeal Reflux | 2 | 2018 | 15 | 0.560 |
Why?
| | Acids | 1 | 2016 | 18 | 0.530 |
Why?
| | Cough | 3 | 2022 | 121 | 0.510 |
Why?
| | Cicatrix | 2 | 2015 | 64 | 0.510 |
Why?
| | Immunity, Mucosal | 1 | 2016 | 97 | 0.490 |
Why?
| | Bacteria | 3 | 2017 | 855 | 0.430 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2016 | 392 | 0.420 |
Why?
| | Microbiota | 2 | 2017 | 763 | 0.370 |
Why?
| | Smoking | 1 | 2016 | 1633 | 0.300 |
Why?
| | Fibroblasts | 2 | 2013 | 990 | 0.300 |
Why?
| | Postoperative Complications | 1 | 2019 | 2627 | 0.280 |
Why?
| | Voice Disorders | 3 | 2011 | 22 | 0.260 |
Why?
| | Phonation | 4 | 2015 | 9 | 0.230 |
Why?
| | Immunohistochemistry | 3 | 2019 | 1739 | 0.210 |
Why?
| | Middle Aged | 12 | 2022 | 33118 | 0.190 |
Why?
| | Laryngoscopy | 2 | 2014 | 105 | 0.180 |
Why?
| | Laryngeal Nerves | 1 | 2020 | 7 | 0.180 |
Why?
| | Voice Training | 2 | 2018 | 6 | 0.180 |
Why?
| | Dysphonia | 2 | 2018 | 15 | 0.170 |
Why?
| | Apnea | 1 | 2020 | 22 | 0.170 |
Why?
| | Voice Quality | 2 | 2010 | 18 | 0.170 |
Why?
| | Reflex | 1 | 2020 | 69 | 0.170 |
Why?
| | Aged | 8 | 2021 | 23641 | 0.170 |
Why?
| | Lasers, Gas | 1 | 2019 | 5 | 0.170 |
Why?
| | Acoustics | 2 | 2010 | 53 | 0.160 |
Why?
| | Brain Stem | 1 | 2020 | 104 | 0.160 |
Why?
| | Electromyography | 3 | 2011 | 400 | 0.160 |
Why?
| | Young Adult | 7 | 2021 | 13157 | 0.150 |
Why?
| | Cost of Illness | 1 | 2021 | 302 | 0.150 |
Why?
| | Nerve Fibers | 1 | 2019 | 96 | 0.150 |
Why?
| | Laser Therapy | 1 | 2019 | 134 | 0.140 |
Why?
| | Cadaver | 1 | 2019 | 318 | 0.140 |
Why?
| | Adult | 10 | 2021 | 37595 | 0.140 |
Why?
| | Humans | 20 | 2022 | 136899 | 0.140 |
Why?
| | RNA, Ribosomal, 16S | 2 | 2017 | 544 | 0.140 |
Why?
| | Laryngitis | 1 | 2017 | 4 | 0.140 |
Why?
| | Female | 14 | 2022 | 72703 | 0.130 |
Why?
| | Disease Management | 1 | 2021 | 624 | 0.130 |
Why?
| | DNA, Ribosomal | 1 | 2016 | 85 | 0.130 |
Why?
| | Cell Proliferation | 2 | 2015 | 2471 | 0.130 |
Why?
| | Taste Buds | 1 | 2019 | 212 | 0.130 |
Why?
| | High-Throughput Nucleotide Sequencing | 2 | 2017 | 536 | 0.130 |
Why?
| | Patient Reported Outcome Measures | 1 | 2019 | 398 | 0.120 |
Why?
| | Respiratory System | 1 | 2017 | 158 | 0.120 |
Why?
| | Smoke | 1 | 2016 | 143 | 0.120 |
Why?
| | DNA, Bacterial | 1 | 2016 | 336 | 0.120 |
Why?
| | Cluster Analysis | 1 | 2016 | 502 | 0.120 |
Why?
| | Cigarette Smoking | 1 | 2016 | 102 | 0.120 |
Why?
| | Male | 11 | 2021 | 67308 | 0.110 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2015 | 165 | 0.110 |
Why?
| | Esophageal pH Monitoring | 1 | 2014 | 23 | 0.110 |
Why?
| | Respiratory Mucosa | 1 | 2017 | 322 | 0.110 |
Why?
| | Myofibroblasts | 1 | 2015 | 125 | 0.110 |
Why?
| | Immune Tolerance | 1 | 2016 | 362 | 0.110 |
Why?
| | Manometry | 1 | 2014 | 95 | 0.110 |
Why?
| | Linear Models | 1 | 2016 | 850 | 0.110 |
Why?
| | Blotting, Western | 2 | 2015 | 1227 | 0.110 |
Why?
| | Electric Impedance | 1 | 2014 | 109 | 0.110 |
Why?
| | Healthy Volunteers | 1 | 2014 | 204 | 0.100 |
Why?
| | Sequence Analysis, DNA | 1 | 2016 | 811 | 0.100 |
Why?
| | Quality of Life | 2 | 2022 | 2847 | 0.100 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2014 | 566 | 0.100 |
Why?
| | Homeostasis | 1 | 2016 | 622 | 0.100 |
Why?
| | Phylogeny | 1 | 2016 | 897 | 0.100 |
Why?
| | Communication Disorders | 1 | 2012 | 10 | 0.100 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 344 | 0.090 |
Why?
| | Surveys and Questionnaires | 2 | 2022 | 5730 | 0.090 |
Why?
| | Molecular Biology | 1 | 2012 | 58 | 0.090 |
Why?
| | Macrophage Activation | 1 | 2012 | 201 | 0.090 |
Why?
| | Laryngeal Muscles | 1 | 2010 | 8 | 0.090 |
Why?
| | Actins | 1 | 2013 | 416 | 0.090 |
Why?
| | Speech Disorders | 1 | 2010 | 34 | 0.090 |
Why?
| | Sex Factors | 1 | 2016 | 2067 | 0.080 |
Why?
| | Palpation | 1 | 2010 | 11 | 0.080 |
Why?
| | Voice | 1 | 2010 | 13 | 0.080 |
Why?
| | Neck Muscles | 1 | 2010 | 18 | 0.080 |
Why?
| | Animals | 4 | 2020 | 36915 | 0.080 |
Why?
| | Leukocytes, Mononuclear | 1 | 2012 | 557 | 0.080 |
Why?
| | Retrospective Studies | 4 | 2021 | 15514 | 0.080 |
Why?
| | Gene Expression Profiling | 2 | 2015 | 1769 | 0.080 |
Why?
| | Auditory Perception | 1 | 2010 | 118 | 0.080 |
Why?
| | Age Factors | 1 | 2016 | 3290 | 0.080 |
Why?
| | Reproducibility of Results | 2 | 2014 | 3282 | 0.070 |
Why?
| | Hyaluronic Acid | 1 | 2010 | 223 | 0.070 |
Why?
| | Risk Assessment | 1 | 2016 | 3432 | 0.070 |
Why?
| | Anti-Bacterial Agents | 1 | 2017 | 1790 | 0.060 |
Why?
| | Genomics | 1 | 2012 | 790 | 0.060 |
Why?
| | Severity of Illness Index | 1 | 2014 | 2833 | 0.060 |
Why?
| | Communication | 1 | 2012 | 872 | 0.060 |
Why?
| | Prognosis | 1 | 2014 | 4011 | 0.060 |
Why?
| | Chronic Disease | 2 | 2022 | 1773 | 0.060 |
Why?
| | Cross-Sectional Studies | 1 | 2016 | 5398 | 0.060 |
Why?
| | Proteomics | 1 | 2012 | 1111 | 0.060 |
Why?
| | Macrophages | 1 | 2012 | 1547 | 0.060 |
Why?
| | Mice | 1 | 2019 | 17775 | 0.050 |
Why?
| | Reference Values | 2 | 2015 | 820 | 0.050 |
Why?
| | Cost-Benefit Analysis | 1 | 2021 | 592 | 0.040 |
Why?
| | Symptom Assessment | 1 | 2018 | 126 | 0.030 |
Why?
| | Health Status | 1 | 2022 | 782 | 0.030 |
Why?
| | Airway Remodeling | 1 | 2017 | 64 | 0.030 |
Why?
| | Cells, Cultured | 2 | 2015 | 4204 | 0.030 |
Why?
| | Cell Differentiation | 2 | 2015 | 1976 | 0.030 |
Why?
| | Mucous Membrane | 1 | 2017 | 125 | 0.030 |
Why?
| | Drug Resistance, Bacterial | 1 | 2017 | 180 | 0.030 |
Why?
| | Sus scrofa | 1 | 2015 | 52 | 0.030 |
Why?
| | Microbial Sensitivity Tests | 1 | 2017 | 362 | 0.030 |
Why?
| | X-Ray Microtomography | 1 | 2015 | 94 | 0.030 |
Why?
| | Freezing | 1 | 2015 | 91 | 0.030 |
Why?
| | Models, Anatomic | 1 | 2015 | 97 | 0.030 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2015 | 105 | 0.030 |
Why?
| | Swine | 1 | 2017 | 775 | 0.030 |
Why?
| | Dogs | 1 | 2015 | 411 | 0.030 |
Why?
| | Species Specificity | 1 | 2015 | 593 | 0.030 |
Why?
| | Polymerase Chain Reaction | 1 | 2017 | 1061 | 0.030 |
Why?
| | Inflammation | 2 | 2017 | 2817 | 0.030 |
Why?
| | In Vitro Techniques | 1 | 2015 | 1108 | 0.030 |
Why?
| | Biopsy | 1 | 2017 | 1130 | 0.030 |
Why?
| | Collagen | 1 | 2015 | 446 | 0.030 |
Why?
| | Lipopolysaccharide Receptors | 1 | 2012 | 86 | 0.020 |
Why?
| | Coculture Techniques | 1 | 2012 | 240 | 0.020 |
Why?
| | Treatment Outcome | 2 | 2021 | 10768 | 0.020 |
Why?
| | Imaging, Three-Dimensional | 1 | 2015 | 578 | 0.020 |
Why?
| | Speech Acoustics | 1 | 2011 | 12 | 0.020 |
Why?
| | Cell Adhesion | 1 | 2012 | 466 | 0.020 |
Why?
| | Loudness Perception | 1 | 2010 | 4 | 0.020 |
Why?
| | Speech Production Measurement | 1 | 2010 | 13 | 0.020 |
Why?
| | Sound Spectrography | 1 | 2010 | 19 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2015 | 1945 | 0.020 |
Why?
| | Phonetics | 1 | 2010 | 46 | 0.020 |
Why?
| | Pulmonary Ventilation | 1 | 2011 | 79 | 0.020 |
Why?
| | Judgment | 1 | 2010 | 64 | 0.020 |
Why?
| | Electrodes | 1 | 2010 | 114 | 0.020 |
Why?
| | Injections | 1 | 2010 | 182 | 0.020 |
Why?
| | Speech | 1 | 2010 | 77 | 0.020 |
Why?
| | Wound Healing | 1 | 2012 | 327 | 0.020 |
Why?
| | Observer Variation | 1 | 2010 | 343 | 0.020 |
Why?
| | Lipopolysaccharides | 1 | 2012 | 882 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2021 | 7552 | 0.020 |
Why?
| | Cohort Studies | 1 | 2018 | 5711 | 0.020 |
Why?
| | Language | 1 | 2010 | 299 | 0.020 |
Why?
| | Adolescent | 2 | 2021 | 21402 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2010 | 2030 | 0.010 |
Why?
| | Cytokines | 1 | 2012 | 2078 | 0.010 |
Why?
| | United States | 1 | 2017 | 14595 | 0.010 |
Why?
| | Prospective Studies | 1 | 2010 | 7543 | 0.010 |
Why?
|
|
Jette's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|